Zenotech Laboratories Limited (Zenotech) is an India-based company that is principally engaged in the manufacture and trading of pharmaceuticals. The Company has launched 15 generic chemical oncology and anesthesiology products in India. Zenotech has three biological products: recombinant human granulocyte macrophage-colony stimulating factor (GM-CSF), recombinant human granulocyte colony stimulating factor (G-CSF) and interlukin-2 (IL-2). All the three are used in the cancer therapy area. The Company’s wholly owned subsidiaries include Zenotech Farmaceutica Do Brasil Limitada, Zenotech Laboratories Nigeria Limited and Zenotech Inc. On May 31, 2007, the Company incorporated a wholly owned subsidiary Hemarus Biologicals Limited.
Zenotech Laboratories Limited
BOM:532039 ISIN:INE486F01012
뉴스
어제 호주증시는 전세계 금융계에 다시 찾아온 불안감으로 금융주 중심으로 약세를 보이며 마감했다. S&P/ASX200지수는 33.8포인트(1%)하락하여 3442.8를 기록했으며 AO지수는 30.2포인트(0.9%)가 하락한 3394.8에 머물렀다. ASIC(호주증권투자위원회)의 금융주 차입 공매도금지 조치는 금융계에 긍정적 효과로 작용할 것이다.
###
39,597 회사 소개
- 검색 횟수: (지난 7일간: 11) (지난 30일간: 34) (게재 이후: 5780)